Quick Answer
PharmaCyte Biotech, Inc. reported Common Stock Shares Outstanding of 6.80 million shares for the year ending 2025.
- PharmaCyte Biotech, Inc. showed a decrease of -15.5% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from PharmaCyte Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on August 11, 2025.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), PharmaCyte Biotech, Inc.'s Common Stock Shares Outstanding has declined by 98.4%.
- Historical annual values: Fiscal year 2025: 6.80 million shares | Fiscal year 2024: 8.04 million shares | Fiscal year 2023: 16.79 million shares | Fiscal year 2022: 20.72 million shares | Fiscal year 2021: 1.59 million shares | Fiscal year 2020: 1.09 million shares | Fiscal year 2019: 1.19 billion shares | Fiscal year 2018: 1.01 billion shares | Fiscal year 2017: 905.35 million shares | Fiscal year 2016: 781.23 million shares | Fiscal year 2015: 732.76 million shares | Fiscal year 2014: 690.62 million shares | Fiscal year 2013: 482.11 million shares | Fiscal year 2012: 416.29 million shares.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: